Key result
Pulmonary thromboendarterectomy improved mean pulmonary artery pressure from 45 to 24 mmHg and reduced functional class from 3.1 to 2.2, with an in-hospital mortality of 4.2%.
Why the study?
Does pulmonary thromboendarterectomy improve hemodynamics, right heart function, and clinical symptoms in patients with chronic thromboembolic pulmonary hypertension at a regional center?
Observational (n=71)
No
Does pulmonary thromboendarterectomy improve hemodynamics, right heart function, and clinical symptoms in patients with chronic thromboembolic pulmonary hypertension at a regional center?
Pulmonary thromboendarterectomy performed at a regional center significantly improves hemodynamics, right heart function, and symptoms in patients with CTEPH, with low in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Supports regional PTE feasibility with hemodynamic and functional gains; leaves open durability versus national centers.
BACKGROUND: Pulmonary thromboendarterectomy (PTE) is the treatment of choice for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, access to CTEPH and PTE care is limited. There is a paucity of published data on PTE efficacy and outcomes from alternative, regional centers of excellence in CTEPH and PTE care in the USA, outside a single national and international referral center. METHODS: We performed a retrospective review of patients undergoing PTE at our institution from June 2013 to December 2016 (42 months), and collected clinical, echocardiographic and hemodynamic data on our patients pre- and post-PTE (N.=71). RESULTS: Patients age ranged between 20-83 years (mean±SD: 56±16), with 54% of patients female and 61% Caucasians. The predominant symptom was shortness of breath with a median duration of symptoms of 17 months. Following PTE, clinical improvements included a reduction in NYHA class from 3.1±1.1 to 2.2±1.2. There were major improvements in hemodynamics and echocardiographic parameters pre- versus post-PTE: mean pulmonary artery pressure (mmHg) 45±11 to 24±8, cardiac index (L/min/m2) 2.1±0.5 to 2.8±0.5, pulmonary vascular resistance (mmHg/L/min) 8.9±4.5 to 2.8±1.8, ratio of right ventricle (RV): left ventricle (LV) 1.2±0.3 to 0.9±0.2, RV fractional area change (%) 23±14 to 44±13, reduction in the incidence of RV outflow tract Doppler notching and improved pulmonary artery acceleration time (96% to 30%, and 74±19 to 111±21). In-hospital mortality was 4.2% (3 patients). CONCLUSIONS: Herein, we report for the first time, the improvements in patient functionality, hemodynamics, right heart function and outcomes at a major regional PTE program.
No takes yet. Share an insight, caveat, or question.
Raza et al. (2018) conducted an observational in Chronic thromboembolic pulmonary hypertension (CTEPH) (n=71). Pulmonary thromboendarterectomy (PTE) vs. Pre-PTE baseline was evaluated on Mean pulmonary artery pressure (mmHg). Pulmonary thromboendarterectomy improved mean pulmonary artery pressure from 45 to 24 mmHg and reduced functional class from 3.1 to 2.2, with an in-hospital mortality of 4.2%.
Synapse has enriched 10 related papers. Consider them for comparative context: